Reich-Zeliger S - Search Results

1

Deletion of cognate CD8 T cells by immature dendritic cells: a novel role for perforin, granzyme A, TREM-1, and TLR7.

Zangi L, Klionsky YZ, Yarimi L, Bachar-Lustig E, Eidelstein Y, Shezen E, Hagin D, Ito Y, Takai T, Reich-Zeliger S, Lask A, Milstein O, Jung S, Shinder V, Reisner Y. Zangi L, et al. Blood. 2012 Aug 23;120(8):1647-57. doi: 10.1182/blood-2012-02-410803. Epub 2012 Jul 9. Blood. 2012. PMID: 22776817 Free article.

2

Anti-third party CD8+ CTLs as potent veto cells: coexpression of CD8 and FasL is a prerequisite.

Reich-Zeliger S, Zhao Y, Krauthgamer R, Bachar-Lustig E, Reisner Y. Reich-Zeliger S, et al. Immunity. 2000 Oct;13(4):507-15. doi: 10.1016/s1074-7613(00)00050-9. Immunity. 2000. PMID: 11070169 Free article.

3

Bone marrow transplantation across major genetic barriers: the role of megadose stem cells and nonalloreactive donor anti-third party CTLS.

Bachar-Lustig E, Reich-Zeliger S, Gur H, Zhao Y, Krauthgamer R, Reisner Y. Bachar-Lustig E, et al. Transplant Proc. 2001 May;33(3):2099-100. doi: 10.1016/s0041-1345(01)01962-5. Transplant Proc. 2001. PMID: 11377465 Review. No abstract available.

4

T cells from newborn humans are fully capable of developing into cytotoxic T lymphocyte effector cells in adoptive hosts.

Marcus H, Dekel B, Arditti FD, Reich-Zeliger S, Segal H, Bocher WO, Reisner Y. Marcus H, et al. Transplantation. 2002 Mar 15;73(5):803-10. doi: 10.1097/00007890-200203150-00025. Transplantation. 2002. PMID: 11907431

5

Human and porcine early kidney precursors as a new source for transplantation.

Dekel B, Burakova T, Arditti FD, Reich-Zeliger S, Milstein O, Aviel-Ronen S, Rechavi G, Friedman N, Kaminski N, Passwell JH, Reisner Y. Dekel B, et al. Nat Med. 2003 Jan;9(1):53-60. doi: 10.1038/nm812. Epub 2002 Dec 23. Nat Med. 2003. PMID: 12496960

6

Anti-third-party veto CTLs overcome rejection of hematopoietic allografts: synergism with rapamycin and BM cell dose.

Bachar-Lustig E, Reich-Zeliger S, Reisner Y. Bachar-Lustig E, et al. Blood. 2003 Sep 15;102(6):1943-50. doi: 10.1182/blood-2003-03-0759. Epub 2003 May 29. Blood. 2003. PMID: 12775573 Free article.

7

Hematopoietic stem cell transplantation across major genetic barriers: tolerance induction by megadose CD34 cells and other veto cells.

Reisner Y, Gur H, Reich-Zeliger S, Martelli MF, Bachar-Lustig E. Reisner Y, et al. Ann N Y Acad Sci. 2003 May;996:72-9. doi: 10.1111/j.1749-6632.2003.tb03235.x. Ann N Y Acad Sci. 2003. PMID: 12799285

8

Crossing the HLA barriers.

Reisner Y, Gur H, Reich-Zeliger S, Martelli MF, Bachar-Lustig E. Reisner Y, et al. Blood Cells Mol Dis. 2004 Nov-Dec;33(3):206-10. doi: 10.1016/j.bcmd.2004.08.004. Blood Cells Mol Dis. 2004. PMID: 15528132 Review.

9

Tolerance induction by veto CTLs in the TCR transgenic 2C mouse model. I. Relative reactivity of different veto cells.

Reich-Zeliger S, Bachar-Lustig E, Gan J, Reisner Y. Reich-Zeliger S, et al. J Immunol. 2004 Dec 1;173(11):6654-9. doi: 10.4049/jimmunol.173.11.6654. J Immunol. 2004. PMID: 15557156

10

Tolerance induction by veto CTLs in the TCR transgenic 2C mouse model. II. Deletion of effector cells by Fas-Fas ligand apoptosis.

Reich-Zeliger S, Gan J, Bachar-Lustig E, Reisner Y. Reich-Zeliger S, et al. J Immunol. 2004 Dec 1;173(11):6660-6. doi: 10.4049/jimmunol.173.11.6660. J Immunol. 2004. PMID: 15557157

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

45 results

Search Page

Filters